[TOVX] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[TOVX] Theriva Biologics, Inc.
Announcement Date
30-Sep-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 7.09%
YoY- -133.91%
Quarter Report
TOVX's Result
TOVX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -7,726 -3,830 -4,853 -3,273 -2,111 -5,150 -3,689 13.09%
Tax 0 -527 -152 0 -8 -30 -640 -
NP -7,726 -3,303 -4,701 -3,273 -2,103 -5,120 -3,680 13.14%
Tax Rate - - - - - - - -
Total Cost 7,726 3,303 4,701 3,273 2,103 5,120 3,680 13.14%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -6.81 -4.85 -0.30 -0.25 -1.08 -3.05 -9.14 -4.78%
EPS Diluted -6.81 -4.85 -0.30 -0.25 -1.08 -3.05 -9.14 -4.78%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.